Tidemark’s Evogene EVGN Stock Holding History

Tidemark’s Portfolio EVGN Stock Details EVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-30	Closed	-$38	–	717
2025 Q1	$38	Buy	+30	New	+$45	﹤0.01%	701

Other funds holding EVGN

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Tidemark's EVGN Position: Q2 2025 in Review

Tidemark sold out of Evogene (EVGN) in Q2 2025, closing a stake of 30 shares — an estimated $38 sold.

Tidemark first reported a position in EVGN in Q1 2025 and held it in 1 quarter. The position peaked at $38 in Q1 2025. 16 funds tracked by Wall St. Rank hold EVGN as of Q2 2025.

Tidemark reported no remaining Evogene position as of Q2 2025 after selling out during the quarter.
Tidemark sold 30 Evogene shares in Q2 2025, an estimated $38.
Tidemark first reported a position in Evogene in Q1 2025 and held it in 1 quarter.
Tidemark's Evogene position peaked at $38 in Q1 2025.
16 funds tracked by Wall St. Rank held Evogene as of Q2 2025.

Based on Tidemark's 13F filing for Q2 2025, filed 11 Aug 2025.